Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Stocks - Hertz Slumps in Premarket on Bankruptcy Fears; FCA Edges up

Published 05/05/2020, 14:04
Updated 05/05/2020, 14:06
© Reuters.

© Reuters.

By Geoffrey Smith 

Investing.com -- Stocks in focus in premarket trade on Tuesday, May 5th. Please refresh for updates.

  • Hertz Global (NYSE:HTZ) stock fell 11.7% on reports that the car hire company may file for bankruptcy as early as this week.
  • Norwegian Cruise Line (NYSE:NCLH) stock fell 6.6% after the company filed to raise $1 billion in fresh capital, of which $350 million will be new shares and the remainder in convertible notes.
  • Marathon Petroleum (NYSE:MPC) stock rose 6.9% after the refiner reported a smaller-than-expected loss for the first quarter.
  • Fiat Chrysler Automobiles (NYSE:FCAU) stock rose 2.2% after the carmaker swung to a loss of $1.8 billion in the first quarter and pulled its guidance for the rest of the year.
  • The company said it was still committed to its merger with French group Peugeot (OTC:PUGOY)..
  • Exxon Mobil (NYSE:XOM) stock rose 3.3% as crude oil prices extended their rebound on signs of a smaller imbalance between supply and demand in the near term. 
  • Independent oil producers Diamondback Energy (NASDAQ:FANG) and Parsley Energy (NYSE:PE) stock also rose after they announced cuts of between 10% and 20% in output this month. Diamondback stock was up 6.8% while Parsley Energy stock was up 5.3%.
  • Pfizer (NYSE:PFE) stock was up 2.3% after it announced the start of human trials for its experimental coronavirus vaccine, which it's developing in partnership with BionTech.
  • DuPont (NYSE:DD) stock rose 2.3% after the company said it had put on ice $500 million of planned capital expenditure. It also said it expected to save $180 million from measures announced earlier in the year.
  • Alaska Air (NYSE:ALK) stock was up 5.0% after the airline announced a smaller-than-expected loss for the quarter.
  • Regeneron (NASDAQ:REGN) stock rose 4.1% after it announced better than expected earnings for the first quarter. The highlight was its eczema treatment Dupixent, which more than doubled revenues to around one-third of the group total.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.